Abstract: Accurate diagnosis of cerebral tumors is crucial for effective clinical therapeutics and prognosis. However, limitations in brain biopsy tissues and the scarcity of pathologists specializing ...

Editor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

HONOLULU — A novel “moderate-affinity iron chaperone” known as ATH434 (Alterity Therapeutics) may slow disease progression in patients with multiple system atrophy (MSA), new research suggested. The ...

Takeda has given up on an AstraZeneca-partnered neurological disorder program after the therapy flunked a phase 2 study. The Japanese pharma had been evaluating the alpha-synuclein antibody, called ...

A panelist discusses how retina specialists, residents, and fellows manage geographic atrophy by emphasizing early diagnosis, navigating new anticomplement therapies, and improving patient ...

Researchers have developed an AI system called Dr. CaBot that spells out its reasoning as it works through challenging medical cases and reaches a diagnosis. For the first time, the New England ...

Purpose To evaluate the diagnostic accuracy of six imaging modalities—colour fundus photography (CFP), multicolour imaging (MC), blue autofluorescence (BAF), green autofluorescence (GAF), ...

aMultiple Sclerosis Centre of Catalonia and Department of Neurology, Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona, Barcelona, Spain bSection of Neuroradiology, Department of ...

1 Clinical Research Center, Xuanwu Hospital Capital Medical University, Beijing, China 2 Department of Neurology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, ...

Teva Pharmaceuticals (NYSE:TEVA) said that the U.S. FDA has granted fast track designation to its experimental therapy TEV-56286 (emrusolmin) for treating Multiple System Atrophy. Emrusolmin, ...